These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7836783)

  • 41. Clinical significance of anti-Sm antibody in systemic lupus erythematosus & related disorders.
    Singh RR; Malaviya AN; Kailash S; Varghese T
    Indian J Med Res; 1991 Jun; 94():206-10. PubMed ID: 1834551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibodies to C reactive protein.
    Rosenau BJ; Schur PH
    Ann Rheum Dis; 2006 May; 65(5):674-6. PubMed ID: 16176996
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Circulating immune complexes in glomerulonephritis and systemic lupus erythematosus. Clinico-immunological correlations].
    Shishkin VI; Belendir ME; Pigareva NV; Klemina IK
    Ter Arkh; 1981; 53(6):30-4. PubMed ID: 6456567
    [No Abstract]   [Full Text] [Related]  

  • 44. [Immunologic anomalies in inflammatory diseases of connective tissue in children].
    Popescu V; Arion C; Dragomir D; Bleahu D; Popescu D; Hurduc V; Tiţeica M; Mateescu D; Ilinca D
    Rev Pediatr Obstet Ginecol Pediatr; 1989; 38(2):161-72. PubMed ID: 2511614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Virus antibodies in systemic lupus erythematosus and other connective tissue diseases.
    Phillips PE; Christian CL
    Ann Rheum Dis; 1973 Sep; 32(5):450-6. PubMed ID: 4127423
    [No Abstract]   [Full Text] [Related]  

  • 46. Immune complexes in human diseases: a review.
    Theofilopoulos AN; Dixon FJ
    Am J Pathol; 1980 Aug; 100(2):529-94. PubMed ID: 6157327
    [No Abstract]   [Full Text] [Related]  

  • 47. [Serum and articular immune complexes detection by the antibody-dependent cytotoxicity inhibition reaction in inflammatory rheumatological conditions and connective tissue disorders (author's transl)].
    Meyer O; Descamps B; Ryckewaert A; Peltier A
    Nouv Presse Med; 1979 Mar; 8(14):1165-9. PubMed ID: 313556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prolactin in connective tissue diseases].
    Parada-Turska J; Targońska-Stepniak B; Majdan M
    Postepy Hig Med Dosw (Online); 2006; 60():278-85. PubMed ID: 16715039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cold lymphocytotoxins in connective tissue disorders.
    Browning JD; Dick HM; Sturrock R; Grennan D; Dick WC
    Scott Med J; 1979 Jan; 24(1):5-8. PubMed ID: 386498
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complement-fixing ability of antinuclear factors. Studies in adult and juvenile rheumatoid arthritis and systemic lupus erythematosus.
    Cossio PM; Arana RM; Morteo OG; Hübscher O; Roux EB
    Ann Rheum Dis; 1971 Nov; 30(6):640-4. PubMed ID: 5316115
    [No Abstract]   [Full Text] [Related]  

  • 51. Current concepts in connective tissue disorders.
    Holborow J
    Br J Hosp Med; 1979 Jul; 22(1):8, 13-4. PubMed ID: 157790
    [No Abstract]   [Full Text] [Related]  

  • 52. Biologic Therapies for Autoimmune and Connective Tissue Diseases.
    Wolfe RM; Ang DC
    Immunol Allergy Clin North Am; 2017 May; 37(2):283-299. PubMed ID: 28366477
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic lupus erythematosus and allied disorders in pregnancy.
    Scott JS
    Clin Obstet Gynaecol; 1979 Dec; 6(3):461-71. PubMed ID: 389524
    [No Abstract]   [Full Text] [Related]  

  • 54. An immunoradiometric assay for erythrocyte complement (C3b) receptor activity applied to a pediatric population with connective tissue disease.
    Buffone GJ; Leatherwood CM; Person DA; Brewer EJ
    Clin Chem; 1983 Oct; 29(10):1720-3. PubMed ID: 6616816
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A nephelometric study of the reaction of monoclonal rheumatoid factor with heat aggregated gamma globulin and sera from patients with immune complex diseases.
    Roberts-Thomson PJ; Bradley J
    Clin Exp Immunol; 1979 Sep; 37(3):408-15. PubMed ID: 92379
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibodies to ribosomal ribonucleoprotein. Prevalence in systemic rheumatic diseases and partial characterization of the antigen.
    Cortés JJ; Mendoza F; Reyes PA
    J Rheumatol; 1987 Aug; 14(4):727-31. PubMed ID: 3118019
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of proteins that interact with the IL-2 regulatory region in patients with rheumatic diseases.
    Becker H; Stengl G; Stein M; Federlin K
    Clin Exp Immunol; 1995 Mar; 99(3):325-30. PubMed ID: 7882553
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune complexes and connective tissue disease.
    Kaplan AP
    Bull N Y Acad Med; 1981 Sep; 57(7):638-49. PubMed ID: 6456027
    [No Abstract]   [Full Text] [Related]  

  • 59. [Determination of immune complexes in renal diseases (author's transl)].
    Smolen JS; Wolf A; Scherak O; Syre G; Pinggera W; Stummvoll HK; Leithner C; Menzel EJ
    Acta Med Austriaca; 1981; 8(2):37-41. PubMed ID: 6456639
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease.
    Skriner K; Sommergruber WH; Tremmel V; Fischer I; Barta A; Smolen JS; Steiner G
    J Clin Invest; 1997 Jul; 100(1):127-35. PubMed ID: 9202064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.